Delivery Order SPE2DB24D1201-SPE2DB25FJDUN
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $9.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $42,553.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management and diabetes treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $25,048.41 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,090.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed-price delivery order is non-competitive and represents a single shipment of the diabetes and weight management medication to support federal healthcare requirements. The contract will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025....
- The Defense Logistics Agency has awarded a delivery order valued at $2,425.15 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens, a glucagon-like peptide-1 (GLP-1) receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by July 24, 2025. The award was issued on July 23, 2025, with performance to be executed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,478.28 by the Defense Logistics Agency on August 14, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 15, 2025. This award falls under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $12,879.01 for Zepbound 5 mg/0.5 mL pen injectors, a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract utilizes no set-aside designation, indicating open...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,050.40 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $11,086.64 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL), a GLP-1 receptor agonist medication used for weight management. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,506.79 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement for a pharmaceutical product commonly used in diabetes and weight management treatment. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance of work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 14, 2025, with a ceiling value of $1,143.87. This non-set-aside, competitively awarded contract calls for the delivery of Zepbound 15 mg/0.5 mL pen injections, a GLP-1 receptor agonist medication used in weight management and diabetes treatment. The order is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be...